Tue, 20 June 2017
he grocery industry is bracing itself for further disruption as e-commerce giant Amazon announced a surprise buyout of Whole Foods Market. Meanwhile, the Nordstrom family is weighing their options for taking the department store private. Thanks to Thumbtack for supporting the Motley Fool. Hire local, skilled pros for just about anything at thumbtack.com today. |
Mon, 19 June 2017
If you're a recent graduate, congratulations! Here's what you need to know about your money. |
Fri, 16 June 2017
Apple is one of the most bet against stocks in the market... kind of. We explain why it's true, but kind of a misleading stat. |
Thu, 15 June 2017
GE’s CEO may have just retired, but he left the company perfectly positioned for a green-energy fueled future. |
Wed, 14 June 2017
A Supreme Court decision that speeds biosimilar drugs to market makes investing in biosimilar stocks even more enticing. |
Tue, 13 June 2017
Discount supermarket chain Aldi will be investing billions in the U.S. market over the next five years, while its fellow German-based rival Lidl prepares to open its first U.S. locations this week. But the biggest winner from this growing competition will be the U.S. consumer. |
Mon, 12 June 2017
The House of Representatives voted last week in favor of the Financial CHOICE Act, which is designed to roll back the enhanced regulatory regime laid out in the Dodd-Frank Act of 2010. On this episode of Industry Focus, we dig into the Financial CHOICE Act and discuss what this means for banks. |
Fri, 9 June 2017
The average investor has a wealth of information at their fingertips, they just need to know where to find it. We talk about our favorite free tools and resources, and Michael Douglass explains why he thinks "the numbers obscure the true story." |
Thu, 8 June 2017
Railroad stocks have consistently beaten the market – here’s why investors should give them a look today. |
Wed, 7 June 2017
Bluebird bio, TG Therapeutics, and Loxo Oncology investors are smiling following bullish presentations for their respective cancer drugs at the annual American Society of Clinical Oncology conference this week. |